Seqme S.R.O.Branch (foreign co.)
Other retail sale of new goods in specialised stores
Overview
Seqme S.R.O. provides DNA sequencing using Illumina, ONT and Sanger methods, DNA extraction and bioinformatics services. The company analyzes soil, water and human microbiomes, performs DNA metabarcoding and eDNA analysis, sells and services Applied Biosystems equipment, and offers courses and workshops.
Financials
Revenue history (in k)
Filing timeliness
Financial statements were filed on time, on average 4 days early.
- 202508/07/2026
- 202414/07/2025
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2025.
Results vs industry
Industry
Offer
- DNA sequencing
- DNA isolation
- Microbiome analysis
- eDNA analysis
- Sample collection kits
- Bioinformatics services
- Bioinformatics courses
Website technology
- Analytics and marketing
- Google Tag Manager
Public procurement
3 tenders recorded as contractor, with a total value of $8,292.
| Publication date | Subject | Amount | Contracting authority | |
|---|---|---|---|---|
| Sep 30, 2025 | Supply of consumables for UKW in Bydgoszcz | $6,812$6,812 | Uniwersytet Kazimierza Wielkiego w Bydgoszczy | |
| Mar 21, 2024 | Periodic technical inspection services for medical and laboratory equipment and apparatus | $230$230 | Narodowy Instytut Onkologii Im. Marii Skłodowskiej-Curie - Państwowy Instytut Badawczy | |
| Dec 29, 2022 | Supply of reagents and consumables for the implementation of a public health task under NPZ – 3 lots | $1,250$1,250 | Instytut Medycyny Wsi Im. Witolda Chodźki |
Authorized Representatives
Manner of representation
Each member of the management board represents the company independently.
Beneficial owners
No beneficial owners recorded for the branch Seqme S.R.O..
Debt
No entries in the National Debtors Register (KRZ).
Public aid
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Jun 20, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | $918$918 | Prezes Zakładu Ubezpieczeń Społecznych | |
| May 30, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | $1,990$1,990 | Prezes Zakładu Ubezpieczeń Społecznych | |
| May 30, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | $1,696$1,696 | Prezes Zakładu Ubezpieczeń Społecznych |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| A-Biotechsp. z o.o. | $1,048,531.83 | a-biotech.pl | ||
| Bio-Labsp. z o.o. | $320,999.14 | bio-lab.com.pl | ||
| Espensp. z o.o. | $56,231.79 | diather.pl | ||
| Elligo Labssp. z o.o. | $40,080.36 | elligo.com |
Change history
| Date | Event | |
|---|---|---|
| 2025-05-07 | Address change (Ul. Trębacka 4, 00-074, Warszawa → Ul. Apenińska 1a/65, 01-493, Warszawa) | |
| 2018-04-25 | Entered in the register |
FAQ
Last updated: 2026-07-15